1.
2.
Is the weight-loss drug boom moving past the Ozempic era?
(feeds.feedburner.com)
3.
The biggest shift in the weight-loss drug boom may not be Ozempic anymore
(feeds.feedburner.com)
4.
How to secure philanthropic funding in a competitive climate
(feeds.nature.com)
5.
Wegovy Maker Novo Nordisk Strikes Deal With OpenAI to Speed Up Drug Discovery
(feeds.content.dowjones.io)
6.
Novo Nordisk and OpenAI Partner to Speed Drug Discovery
(feeds.content.dowjones.io)
9.
A new weight-loss pill is here, and it could reshape the GLP-1 market
(feeds.feedburner.com)
10.
FDA Approves Eli Lilly's GLP-1 Pill
(wired.com)
11.
Wegovy’s new pricing could save you $1,200—but it’s not for everyone
(feeds.feedburner.com)
12.
Ro CEO on the next phase of the Ozempic boom
(feeds.feedburner.com)
13.
14.
Can weight-loss pills replace injectables? What the science says
(feeds.nature.com)
18.
FDA Approves Pill Version of Wegovy
(wired.com)
Today's top topics:
google
android
gemini
apple
openai
amazon
android 17
android authority
samsung
microsoft